Cargando…
Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis
BACKGROUND: Low levels of ascorbic acid (AA) have been detected in critically ill patients in which AA supplementation leads to promising outcomes. However, the ability of AA to reduce mortality in critically ill patients remains controversial. In this study, we have performed a meta-analysis to eva...
Autores principales: | Wang, Ying, Lin, Huan, Lin, Bing-wen, Lin, Jian-dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6527630/ https://www.ncbi.nlm.nih.gov/pubmed/31111241 http://dx.doi.org/10.1186/s13613-019-0532-9 |
Ejemplares similares
-
Phenytoin Toxicity with High Dose, Concomitant Ascorbic Acid Dosing
por: Schuh, Michael J., et al.
Publicado: (2022) -
Timing of Tracheostomy in Critically Ill Patients: A Meta-Analysis
por: Huang, Huibin, et al.
Publicado: (2014) -
Anti-angiogenic effect of high doses of ascorbic acid
por: Mikirova, Nina A, et al.
Publicado: (2008) -
Ascorbic acid as an adjunctive therapy in critically ill patients with COVID-19: a propensity score matched study
por: Al Sulaiman, Khalid, et al.
Publicado: (2021) -
Predictive Value of Heart-Type Fatty Acid-Binding Protein for Mortality Risk in Critically Ill Patients
por: Zhang, Ye, et al.
Publicado: (2022)